Business Wire: Calviri Completes Enrollment of 800 Dogs in a Preventative Cancer Vaccine Trial
The double-blinded trial is testing Calviri’s vaccine aimed at broadly preventing cancers in dogs. It is being conducted at three leading canine oncology centers – the Flint Animal Cancer Center at CSU, the School of Veterinary Medicine at University of Wisconsin-Madison and the University of California-Davis School of Veterinary Medicine.